Publikationen 2024
Analysis of factors influencing the choice for a centre for obstetrical and gynaecological patients.
Arch Gynecol Obstet 2024;
Ehmann L, Sultova V, Henkel L, Höhn H, Tamalunas A, Tremmel E, Meister S, Beyer S, Seifert C, Starrach T, Jeschke U, Mahner S, Kolben T, Schröder L
Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohort.
BJU Int 2024; 133(5): 548-554;
Chaloupka M, Pyrgidis N, Ebner B, Volz Y, Pfitzinger PL, Berg E, Enzinger B, Atzler M, Ivanova T, Clevert DA, Buchner A, Stief CG, Apfelbeck M
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding.
BJU Int 2024; 134(5): 781-788;
Antonelli L, Wendel-Garcia PD, Deforth M, Afferi L, Leonardo C, Esperto F, Borghesi M, Antonelli A, Tully K, Umari P, Albisinni S, Mari A, Pichler R, Claps F, Teoh JY, Roumiguié M, Schulz GB, Orecchia L, Soria F, Roupret M, Marcq G, Poyet C, Alrumayyan M, Rink M, Zamboni S, Montes MR, Okoye S, Campi R, Krajewski W, Mertens L, Culpan M, Lavallée LT, Moschini M, Held U, Fankhauser CD, EAU YAU urothelial carcinoma working group
Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions.
Biomed Pharmacother 2024; 177
Tamalunas A, Wendt A, Springer F, Vigodski V, Trieb M, Eitelberger N, Poth H, Ciotkowska A, Rutz B, Hu S, Schulz H, Ledderose S, Rogenhofer N, Kolben T, Nössner E, Stief CG, Hennenberg M
The mechanism of resistance to CDK4/6 inhibition and novel combination therapy with RNR inhibition for chemo-resistant bladder cancer.
Cancer Commun (Lond) 2024; 44(6): 700-704;
Tong Z, Zhao Y, Bai S, Ebner B, Lienhard L, Zhao Y, Wang Z, Pan Q, Guo P, Bracht T, Sitek B, Gschwend JE, Xu W, Nawroth R
The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the Bladder.
Cancers (Basel) 2024; 16(8):1536
Tamalunas A, Aydogdu C, Unterrainer LM, Schott M, Rodler S, Ledderose S, Schulz GB, Stief CG, Casuscelli J
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center.
Cancers (Basel) 2024; 16(12):2246
Rodler S, Aydogdu C, Brinkmann I, Berg E, Kopliku R, Götz M, Ivanova T, Tamalunas A, Schulz GB, Heinemann V, Stief CG, Casuscelli J
Effects of Intraoperative Opioid Use and a Combined Anesthesia Protocol in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder—A Single-Center Experience.
Cancers. 2024; 16(19):3411
Marcon J, Yefsah F, Schulz GB, Weinhold P, Rodler S, Eismann L, Volz Y, Pfitzinger PL, Stief CG, Kowalski C, Siegl D, Buchner A, Pyrgidis N, Jokisch JF
The Effect of Resistance and/or Aerobic Training on Quality of Life, Fitness, and Body Composition in Prostate Cancer Patients—A Systematic Review and Meta-Analysis.
Kempin S, Buchner A, Brose SF, Schmidt-Hegemann N, May M, Wolff I, Kravchuk A, Stief C, Brookman-May SD, Enzinger B
Cancers. 2024; 16(24):4286
The use of indocyanine green in partial nephrectomy: a systematic review.
Cent European J Urol 2024; 77(1): 15-21;
Katsimperis S, Tzelves L, Bellos T, Manolitsis I, Mourmouris P, Kostakopoulos N, Pyrgidis N, Somani B, Papatsoris A, Skolarikos A
Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal.
Clin Genitourin Cancer 2024; 22(2): 189-192;
Staehler M, Rodler S, Brinkmann I, Stief CG, Graser A, Götz M, Herlemann A
Improved diagnostic confidence using Super Resolution CEUS imaging in testicular lesions.
Clin Hemorheol Microcirc 2024; 88(s1): S113-S125;
Apfelbeck M, Loupas T, Chaloupka M, Clevert DA
mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center.
Clin Hemorheol Microcirc 2024; 86(1-2): 63-70;
Chaloupka M, Pyrgidis N, Ebner B, Pfitzinger P, Volz Y, Berg E, Abrarova B, Atzler M, Ivanova T, Pfitzinger P, Stief CG, Apfelbeck M, Clevert DA
Physician reported toxicities and patient reported quality of life of transperineal ultrasound-guided radiotherapy of prostate cancer.
Clin Trans Rad Onc 2024; 49: 100868;
Ma J, Rogowski P, Trapp C, Manapov F, Xu B, Buchner A, Lu S, Schmidt-Hegemann N, Wang X, Zhou C, Stief C, Belka C, Li M
PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer.
EJNMMI Rep 2024; 8(1)
Sheikh GT, Trapp C, Schmidt-Hegemann NS, Buchner A, Stief CG, Unterrainer M, Kunz WG, Cyran CC, Grawe F, Delker A, Zacherl MJ, Holzgreve A, Unterrainer LM, Brendel M, Belka C, Li M, Rogowski P
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis.
Eur J Nucl Med Mol Imaging 2024;
Trapp C, Aebersold DM, Belka C, Casuscelli J, Emmett L, Eze C, Fanti S, Farolfi A, Fendler W, Grosu AL, Guckenberger M, Hruby G, Kirste S, Koerber SA, Kroeze S, Peeken JC, Rogowski P, Scharl S, Shelan M, Spohn SKB, Strouthos I, Unterrainer L, Vogel M, Wiegel T, Zamboglou C, Schmidt-Hegemann NS
[68Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study.
Eur J Nucl Med Mol Imaging 2024; 51(11): 3461-3464
Eismann L, Ledderose ST, Enzinger B, Berg E, Westhofen T, Rodler S, Schulz GB, Toms J, Holzgreve A, Gildehaus FJ, Brendel M, Cyran CC, Unterrainer M, Stief CG, Bartenstein P, Schlenker B, Unterrainer LM
[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
Eur J Nucl Med Mol Imaging 2024;
Unterrainer LM, Eismann L, Lindner S, Gildehaus FJ, Toms J, Casuscelli J, Holzgreve A, Kunte SC, Cyran CC, Menold P, Karl A, Unterrainer M, Ledderose ST, Stief CG, Bartenstein P, Kretschmer A, Schulz GB
Self-reported exhaustion and a 4-item physical frailty index to predict the incidence of major complications after onco-geriatric surgery.
Eur J Surg Oncol 2024; 50(7);
Scholtz K, Borchers F, Mörgeli R, Krampe H, Schmidt M, Eckardt-Felmberg R, von Dossow V, Sehouli J, Stief CG, Pohrt A, Spies CD, PERATECS Group
Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
Eur Radiol 2024; 34(2): 1157-1166;
Grawe F, Blom F, Winkelmann M, Burgard C, Schmid-Tannwald C, Unterrainer LM, Sheikh GT, Pfitzinger PL, Kazmierczak P, Cyran CC, Ricke J, Stief CG, Bartenstein P, Ruebenthaler J, Fabritius MP, Geyer T
Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology.
Eur Urol 2024; 85(2): 146-153;
Eppler M, Ganjavi C, Ramacciotti LS, Piazza P, Rodler S, Checcucci E, Gomez Rivas J, Kowalewski KF, Belenchón IR, Puliatti S, Taratkin M, Veccia A, Baekelandt L, Teoh JY, Somani BK, Wroclawski M, Abreu A, Porpiglia F, Gill IS, Murphy DG, Canes D, Cacciamani GE
Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.
Eur Urol 2024; 85(6): 565-573;
Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study.
Eur Urol 2024; 85(6): 511-516
Weber M, Fendler WP, Ravi Kumar AS, Calais J, Czernin J, Ilhan H, Saad F, Kretschmer A, Hekimsoy T, Brookman-May SD, Mundle SD, Small EJ, Smith MR, Perez PM, Hope TA, Herrmann K, Hofman MS, Eiber M, Hadaschik BA
Biophotonics-Intraoperative Guidance During Partial Nephrectomy: A Systematic Review and Meta-analysis.
Eur Urol Focus 2024; 10(2): 248-258;
Egen L, Demmel GS, Grilli M, Studier-Fischer A, Nickel F, Haney CM, Mühlbauer J, Hartung FO, Menold HS, Piazza P, Rivas JG, Checcucci E, Puliatti S, Belenchon IR, Taratkin M, Rodler S, Cacciamani G, Michel MS, Kowalewski KF
Evolution of Robotic Urology in Clinical Practice from the Beginning to Now: Results from the GRAND Study Register.
Eur Urol Focus 2024;
Pyrgidis N, Volz Y, Ebner B, Westhofen T, Staehler M, Chaloupka M, Apfelbeck M, Jokisch F, Bischoff R, Marcon J, Weinhold P, Becker A, Stief C, Schulz GB
Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer.
Eur Urol Focus 2024;
Khadhouri S, Hramyka A, Gallagher K, Light A, Ippoliti S, Edison M, Alexander C, Kulkarni M, Zimmermann E, Nathan A, Orecchia L, Banthia R, Piazza P, Mak D, Pyrgidis N, Narayan P, Abad Lopez P, Nawaz F, Tran TT, Claps F, Hogan D, Gomez Rivas J, Alonso S, Chibuzo I, Gutierrez Hidalgo B, Whitburn J, Teoh J, Marcq G, Szostek A, Bondad J, Sountoulides P, Kelsey T, Kasivisvanathan V, IDENTIFY Study Group
Patients' Trust in Artificial Intelligence-based Decision-making for Localized Prostate Cancer: Results from a Prospective Trial.
Eur Urol Focus 2024; 10(4): 654-661;
Rodler S, Kopliku R, Ulrich D, Kaltenhauser A, Casuscelli J, Eismann L, Waidelich R, Buchner A, Butz A, Cacciamani GE, Stief CG, Westhofen T
Readability Assessment of Patient Education Materials on Uro-oncological Diseases Using Automated Measures.
Eur Urol Focus 2024;
Rodler S, Maruccia S, Abreu A, Murphy D, Canes D, Loeb S, Malik RD, Bagrodia A, Cacciamani GE
Reply to Marco Moschini, Francesco Montorsi, Giuseppe Rosiello, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Stamatios Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920-9.
Eur Urol Focus 2024; 10(5)
Katsimperis S, Tzelves L, Tandogdu Z, Ta A, Geraghty R, Bellos T, Manolitsis I, Pyrgidis N, Schulz GB, Sridhar A, Shaw G, Kelly J, Skolarikos A
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney.
Eur Urol Oncol 2024; 7(6): 1527-1534;
Tan VS, Correa RJM, Warner A, Ali M, Muacevic A, Ponsky L, Ellis RJ, Lo SS, Onishi H, Swaminath A, Suk Kwon Y, Morgan SC, Cury FL, Teh BS, Mahadevan A, Kaplan ID, Chu W, Hannan R, Staehler M, Zaorsky NG, Louie AV, Siva S
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
Eur Urol Oncol 2024; 7(4): 721-734;
Rajwa P, Robesti D, Chaloupka M, Zattoni F, Giesen A, Huebner NA, Krzywon A, Miszczyk M, Moll M, Stando R, Cisero E, Semko S, Checcucci E, Devos G, Apfelbeck M, Gatti C, Marra G, van den Bergh RCN, Goldner G, Rasul S, Ceci F, Dal Moro F, Porpiglia F, Gontero P, Bjartell A, Stief C, Heidenreich A, Joniau S, Briganti A, Shariat SF, Gandaglia G, EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party
Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free Interval.
Eur Urol Oncol 2024;
Hoeh B, Preisser F, Zattoni F, Kretschmer A, Westhofen T, Olivier J, Soeterik TFW, van den Bergh RCN, Mandel P, Graefen M, Tilki D, EAU-YAU Prostate Cancer Working Group
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice.
Eur. Urol. Open Sci. 2024; 62(): 54-60;
Warren H, Rautio A, Marandino L, Pyrgidis N, Tzelves L, Roussel E, Muselaers S, Erdem S, Palumbo C, Amparore D, Wu Z, Ciccarese C, Diana P, Borregales L, Pavan N, Pecoraro A, Caliò A, Klatte T, Carbonara U, Marchioni M, Bertolo R, Campi R, Tran MGB
Genetic Predisposition to Benign Prostatic Hyperplasia: Where Do We Stand?
Eur. Urol. Open Sci. 2024; 70(): 154-157;
Hennenberg M, Hu S, Tamalunas A, Stief CG
Isoform-independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells.
FASEB J 2024; 38(7)
Liu Y, Huang R, Wang R, Tamalunas A, Waidelich R, Stief CG, Hennenberg M
Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron.
Front Pharmacol 2024; 15()
Muderrisoglu AE, Ciotkowska A, Rutz B, Hu S, Qian S, Tamalunas A, Stief CG, Hennenberg M
Adrenoceptors in the Lower Urinary Tract.
Handb Exp Pharmacol 2024; 285(): 333-367;
Hennenberg M, Michel MC
[Robotic-assisted harvesting of a latissimus dorsi muscle flap: a case report].
Handchir Mikrochir Plast Chir 2024;
Ehrl D, Nuernberger T, Stief C, Karcz K, Giunta RE
Perioperative outcomes of penile prosthesis implantation in Germany: results from the GRAND study.
Int J Impot Res 2024; 36(8): 848-853;
Pyrgidis N, Schulz GB, Chaloupka M, Volz Y, Pfitzinger PL, Rodler S, Berg E, Weinhold P, Jokisch F, Stief CG, Becker AJ, Marcon J
Response to Comment on Trends and outcomes of hospitalized patients with priapism in Germany: results from the GRAND study.
Int J Impot Res 2024;
Pyrgidis N, Schulz GB, Marcon J
The recommended treatment protocol for low-intensity shockwave therapy based on the severity of erectile dysfunction.
Int J Impot Res 2024;
Pyrgidis N, Kalyvianakis D, Mykoniatis I, Hatzichristou D
Trends and outcomes of hospitalized patients with priapism in Germany: results from the GRAND study.
Int J Impot Res 2024;
Pyrgidis N, Schulz GB, Chaloupka M, Volz Y, Pfitzinger PL, Berg E, Weinhold P, Jokisch F, Stief CG, Becker AJ, Marcon J
Ligand-Receptor Interactions and Structure-Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors.
Int J Mol Sci 2024; 25(13)
Huang R, Yu Q, Tamalunas A, Stief CG, Hennenberg M
Impact of Intraoperative Opioid Use and a Combined Anesthesia Regimen in Patients Undergoing Radical Prostatectomy for Prostate Cancer in a Single-Center Cohort.
J Clin Med 2024; 13(24):7506
Marcon J, Bischoff R, Rattenhuber K, Chaloupka M, Askari D, Jokisch J-F, Becker AJ, Pfitzinger PL, Keller P, Berg E, Stief CG, Siegl D, Kowalski C, Buchner A, Pyrgidis N, Weinhold P
Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data Study.
J Clin Med 2024; 13(12):3531
Pyrgidis N, Moschini M, Tzelves L, Somani BK, Juliebø-Jones P, Del Giudice F, Mertens LS, Pichler R, Volz Y, Ebner B, Eismann L, Semmler M, Pradere B, Soria F, Stief CG, Schulz GB
Radical Cystectomy with Ileal Orthotopic Neobladder after 70 Years Leads to Worse Health-Related Quality of Life.
J Clin Med 2024; 13(20)
Pyrgidis N, Schulz GB, Ebner B, Jokisch F, Eismann L, Karatas D, Fouladgar ST, Hermans J, Keller P, Stief C, Volz Y
Can Multiparametric Ultrasound Analysis Predict Malignancy in Testes? An 11-Year Single Center Experience with Testicular Masses.
J Clin Med 2024; 13(24)
Volz Y, Brinkmann IK, Clevert DA, Pyrgidis N, Keller P, Weinhold P, Jokisch F, Kidess M, Chaloupka M, Stief CG, Marcon J
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
J Clin Oncol 2024; 42(11): 1222-1228;
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK, CLEAR Trial Investigators
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
J Clin Oncol 2024; 42(20): 2446-2455;
Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, Zengerling F, Schwab C, Nagy D, Toma M, Kristiansen G, Heers H, Ivanyi P, Niegisch G, Grunewald CM, Darr C, Farid A, Schlack K, Abbas M, Aydogdu C, Casuscelli J, Mokry T, Mayr M, Niedersüß-Beke D, Rausch S, Dietrich D, Saal J, Ellinger J, Ritter M, Alajati A, Kuppe C, Meeks J, Vera Badillo FE, Nakauma-González JA, Boormans J, Junker K, Hartmann A, Grünwald V, Hölzel M, Eckstein M
Perioperative Outcomes of Same-Session Bilateral vs Unilateral Ureteroscopy for Stone Removal: Results from the GRAND Study.
J Endourol 2024; 38(2): 129-135;
Pyrgidis N, Chaloupka M, Ebner B, Stief C, Weinhold P, Marcon J, Schulz GB
Does climate impact inflatable penile prosthesis infection (IPP) risk? Assessment of temperature and dew point on IPP infections.
J Sex Med 2024; 21(5): 500-504;
Barham DW, Pyrgidis N, Amini E, Hammad M, Miller J, Andrianne R, Burnett AL, Gross K, Hatzichristodoulou G, Hotaling J, Hsieh TC, Jenkins LC, Jones JM, Lentz A, Modgil V, Osmonov D, Park SH, Pearce I, Perito P, Sadeghi-Nejad H, Sempels M, Suarez-Sarmiento A, Simhan J, van Renterghem K, Warner JN, Ziegelmann M, Yafi FA, Gross MS, PUMP (Prosthetic Urology Multi-institutional Partnership) collaborators
The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial.
J Sex Med 2024; 21(6): 533-538;
Kalyvianakis D, Mykoniatis I, Pyrgidis N, Kapoteli P, Zilotis F, Hatzichristou D
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.
JAMA Oncol 2024; 10(6): 755-764;
Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger B, Steiner T, Roghmann F, Niegisch G, Bolenz C, Schmitz M, Baretton G, Leucht K, Schumacher U, Foller S, Zengerling F, Meran J, TITAN-TCC Study Group
Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview Survey.
JCO Oncol Pract 2024; 20(12): 1755-1763
Leonard S, Helstrom E, Correa A, Sindhani M, Uzzo N, Jia AY, Kutikov A, Uzzo R, Psutka SP, Calaway A, Klaassen Z, Staehler M, Smaldone M, Wallis CJD, Bukavina L
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol 2024; 25(5): e193-e204;
Marvaso G, Jereczek-Fossa BA, Zaffaroni M, Vincini MG, Corrao G, Andratschke N, Balagamwala EH, Bedke J, Blanck O, Capitanio U, Correa RJM, De Meerleer G, Franzese C, Gaeta A, Gandini S, Garibaldi C, Gerszten PC, Gillessen S, Grubb WR, Guckenberger M, Hannan R, Jhaveri PM, Josipovic M, Kerkmeijer LGW, Lehrer EJ, Lindskog M, Louie AV, Nguyen QN, Ost P, Palma DA, Procopio G, Rossi M, Staehler M, Tree AC, Tsang YM, Van As N, Zaorsky NG, Zilli T, Pasquier D, Siva S
Hyperspectral imaging for monitoring of free flaps of the oral cavity: A feasibility study.
Lasers Surg Med 2024; 56(2): 165-174;
Felicio-Briegel A, Linek M, Sroka R, Rühm A, Freymüller C, Stocker M, Baumeister P, Reichel C, Volgger V
Influence of vitamins and food on the fluorescence spectrum of human urine.
Lasers Surg Med 2024; 56(5): 485-495;
Chalissery P, Homann C, Stepp H, Eisel M, Aumiller M, Rühm A, Buchner A, Sroka R
Simple Characterization of Cylindrical Diffuser Fibers With a Fluorescent Layer.
Lasers Surg Med 2024; 56(6): 597-605;
Stepp H, Sroka R
[Benign prostatic syndrome - epidemiology, aetiology, diagnostic evaluation].
MMW Fortschr Med 2024; 166(8): 36-39;
Kidess M, Keller P, Tamalunas A, Askari-Motlagh D, Atzler M, Karatas D, Stadelmeier L, Stief CG, Weinhold P
[Interventional therapy procedures in BPH].
MMW Fortschr Med 2024; 166(8): 44-46;
Keller P
[Macrohaematuria].
MMW Fortschr Med 2024; 166(3): 46-48;
Eismann L, Stief CG, Bischoff R
[Medical treatment of non-neurogenic male LUTS].
MMW Fortschr Med 2024; 166(8): 40-43;
Tamalunas A, Keller P, Götz M, Atzler M, Kidess M, Stadelmeier L, Ebner B, Hennenberg M, Stief CG, Weinhold P
Update gutartige Prostatavergrößerung. Editorial.
MMW Fortschr Med 2024; 166(8);
Stief CG
[Systemic treatment options for metastatic prostate cancer].
MMW Fortschr Med 2024; 166(19): 64-69;
Aydogdu CD, Casuscelli J
Grading Challenges and Prognostic Insights in Chromophobe Renal Cell Carcinoma: A Retrospective Study of 72 Patients.
Medicina (Kaunas) 2024; 60(6)
Papanikolaou D, Sokolakis I, Moysidis K, Pyrgidis N, Bobos M, Meditskou S, Hatzimouratidis K
Assessing Stress Induced by Fluid Shifts and Reduced Cerebral Clearance during Robotic-Assisted Laparoscopic Radical Prostatectomy under Trendelenburg Positioning (UroTreND Study).
Methods Protoc 2024; 7(2)
Peschke T, Feuerecker M, Siegl D, Schicktanz N, Stief C, Zu Eulenburg P, Choukér A, Buchheim JI
Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
Naunyn Schmiedebergs Arch Pharmacol 2024; 397(2): 1219-1231;
Hu S, Trieb M, Huang R, Tamalunas A, Keller P, Götz M, Waidelich R, Stief CG, Hennenberg M
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy.
Nutrients 2024; 16(11)
Ebrahimi H, Battle D, Salgia NJ, Zengin ZB, Dizman N, Meza L, Bergerot CD, Barragan-Carrillo R, Hsu J, Castro D, Mercier B, Chawla N, Li X, Tripathi A, Liu ST, Chehrazi-Raffle A, Vaishampayan U, Staehler MD, Pal SK
Phytomedicines in Pharmacotherapy of LUTS/BPH – What Do Patients Think?
Patient Prefer Adherence. 2024;18:2507-2518
Tamalunas A, Paktiaval R, Lenau P, Stadelmeier LF, Buchner A, Kolben T, Magistro G, Stief CG, Hennenberg M
Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications.
Pharmacol Rep 2024;
Hu S, Müderrisoglu AE, Ciotkowska A, Kale O, Keller P, Schott M, Tamalunas A, Waidelich R, Stief CG, Hennenberg M
Photodiagnosis Photodyn Ther 2024; 45()
Aumiller M, Arazar A, Sroka R, Dietrich O, Rühm A
Accuracy of robotic radiosurgery in renal cell carcinoma.
Phys Med 2024; 122
Hofmann T, Kohlhase N, Eftimova D, Eder MM, Staehler M, Ruge MI, Muacevic A, Fürweger C
Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.
Prostate 2024; 84(2): 131-147;
Wang L, Lyu C, Stadlbauer B, Buchner A, Nößner E, Pohla H
Prostate Cancer Prostatic Dis 2024;
Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M, Young Academic Urologists working group on Prostate Cancer of the European Association of Urology
Impact of persistent PSA after salvage radical prostatectomy: a multicenter study.
Prostate Cancer Prostatic Dis 2024; 27(4): 686-692;
Preisser F, Incesu RB, Rajwa P, Chlosta M, Nohe F, Ahmed M, Abreu AL, Cacciamani G, Ribeiro L, Kretschmer A, Westhofen T, Smith JA, Steuber T, Calleris G, Raskin Y, Gontero P, Joniau S, Sanchez-Salas R, Shariat SF, Gill I, Karnes RJ, Cathcart P, Van Der Poel H, Marra G, Tilki D
Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare perspective.
Radiat Oncol 2024; 19(1)
Kramer KKM, Schmidt-Hegemann NS, Westhofen T, Foglar M, Ricke J, Westphalen CB, Unterrainer M, Kunz WG, Mehrens D
Value of contrast-enhanced sonography in the diagnosis of vesicoureteral reflux.
Rofo 2024; 196(10): 1022-1028;
Conen P, Thiemann J, Stredele R, Clevert DA
Sci Rep 2024;14(1):13979;
Pachyn E, Aumiller M, Freymüller C, Linek M, Volgger V, Buchner A, Rühm A, Sroka R
Cell therapy for male sexual dysfunctions: systematic review and position statements from the European Society for Sexual Medicine.
Sex Med 2024; 12(1)
Manfredi C, Boeri L, Sokolakis I, Schifano N, Pyrgidis N, Fernández-Pascual E, Sansone A, García-Gómez B, Albersen M, Corona G, Romero-Otero J, Fode M, ESSM Scientific Collaboration and Partnership (ESCAP)
Standard operating procedure to reveal prostate cancer specific volatile organic molecules by infrared spectroscopy.
Spectrochim Acta A Mol Biomol Spectrosc 2024; 304()
Maiti KS, Fill E, Strittmatter F, Volz Y, Sroka R, Apolonski A
Generative artificial intelligence in surgery.
Surgery 2024; 175(6): 1496-1502;
Rodler S, Ganjavi C, De Backer P, Magoulianitis V, Ramacciotti LS, De Castro Abreu AL, Gill IS, Cacciamani GE
Transfusion 2024; 64(1): 29-38;
Ebner B, Fleckenstein F, Volz Y, Eismann L, Hermans J, Buchner A, Enzinger B, Weinhold P, Wichmann C, Stief CG, Humpe A, Pyrgidis N, Schulz GB
Transitioning from "Dr. Google" to "Dr. ChatGPT": the advent of artificial intelligence chatbots.
Transl Androl Urol 2024; 13(6): 1067-1070;
Checcucci E, Rodler S, Piazza P, Porpiglia F, Cacciamani GE
Gender-Specific Differences in Recurrence and Progression following Bacillus Calmette-Guérin Instillation for Non-Muscle-Invasive Bladder Cancer.
Urol Int 2024; 1-13;
Schneidewind L, Kiss B, Kranz J, Zengerling F, Borkowetz A, Graf S, Graser A, Uhlig A
The impact of ureteral access sheaths on radiation exposure in the ureterorenoscopic treatment of urolithiasis.
Eismann L, Rodler S, Buchner A, Strittmatter F, Alghamdi A, Lennartz S, Grunz JP, Waidelich R, Becker A, Weinhold P, Kretschmer A, Stief CG, Westhofen T
Urol Int. 2024;
The prognostic value of perioperative platelet and leukocyte values in patients undergoing radical cystectomy: a prospective long-term cohort study.
Urol Int 2024; 108(5): 421-428;
Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, Jokisch F
Urol Int 2024; 108(1): 42-48;
Volz Y, Trappmann R, Ebner B, Eismann L, Enzinger B, Hermanns J, Pyrgidis N, Stief C, Schulz GB
Urol Oncol 2024; 42(2): 32.e9-32.e16;
Reese SW, Eismann L, White C, Villada JA, Khaleel S, Ostrovnaya I, Vazquez-Rivera K, Carlo MI, Feldman D, Lee CH, Motzer R, Voss MH, Kotecha RR, Matulewicz RS, Goh A, Coleman J, Russo P, Hakimi AA
Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma with Synchronous and Metachronous Nodal Disease.
Urol Pract 2024;
Eismann L, Zucker M, Dawidek MT, Reese SW, Calderon LP, Aulitzky A, Stief CG, Coleman JA, Kotecha RR, Carlo M, Chen Y, Reznik E, Russo P, Hakimi AA
[Antidepressants for the treatment of depression in people with cancer].
Urologie 2024; 63(5): 488-491;
Graser A
[Paradigm shift in systemic therapy for metastatic urothelial carcinoma-antibody-drug conjugates (ADCs) and fibroblast growth factor receptor (FGFR) inhibitors].
Urologie 2024; 63(10): 1002-1010;
Casuscelli J, von Amsberg G, Retz M
[Perineal prostate biopsy].
Urologie 2024; 63(9): 934-942;
Pfitzinger PL, Askari DA, Ivanova T, Hoffmann M, Blajan I, Atzler M, Stadelmeier LF, Apfelbeck M, Chaloupka M, Kazmierczak P, Stief C, Enzinger B
[Treatment of localized renal cell carcinoma].
Urologie 2024; 63(2): 176-183;
Brinkmann I, Stief CG, Marcon J
Impact of preoperative LUTS on Health-Related Quality of Life following Radical Prostatectomy - A propensity score matched longitudinal study.
Urology 2024;
Westhofen T, Feyerabend E, Buchner A, Schlenker B, Becker A, Eismann L, Rodler S, Jokisch F, Stief CG, Kretschmer A
Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.
World J Urol 2024; 42(1)
Rodler S, Danninger D, Eismann L, Kazmierczak PM, Jokisch F, Li M, Becker A, Kretschmer A, Stief C, Westhofen T
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of life.
World J Urol 2024; 42(1)
Westhofen T, Buchner A, Lennartz S, Rodler S, Eismann L, Aydogdu C, Askari-Motlagh D, Berg E, Feyerabend E, Kazmierczak P, Jokisch F, Becker A, Stief CG, Kretschmer A
Prospective close monitoring of the effect of vascular-targeted photodynamic therapy and high intensity focused ultrasound of localized prostate cancer by multiparametric magnetic resonance imaging.
World J Urol 2024; 42(1)
Solyanik O, Chaloupka M, Clevert DA, Schmidt VF, Ingenerf M, Kazmierczak P, Stief CG, Ricke J, Apfelbeck M
Re: letter to the editor for the article "Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy".
World J Urol 2024; 42(1)
Rodler S, Stief C, Westhofen T
The early learning curve of the bipolar enucleation of the prostate: a multicenter cohort study.
World J Urol 2024; 42(1)
Ramesmayer C, Deininger S, Pyrgidis N, Lusuardi L, Kunit T, Pallauf M, Sieberer M, Drerup M, Fontanella P, Oswald D, Hermann TR, Symeonidis EN, Memmos D, Sountoulides P
The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data.
World J Urol 2024; 42(1)
Pyrgidis N, Volz Y, Ebner B, Kazmierczak PM, Enzinger B, Hermans J, Buchner A, Stief C, Schulz GB
The impact of health care on outcomes of suspected testicular torsion: results from the GRAND study.
World J Urol 2024; 42(1)
Pyrgidis N, Apfelbeck M, Stredele R, Rodler S, Kidess M, Volz Y, Weinhold P, Stief CG, Marcon J, Schulz GB, Chaloupka M
The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study.
World J Urol 2024; 42(1)
Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, Jokisch F
The impact of preoperative 5-alpha reductase inhibitors on functional outcomes and health-related quality of life following radical prostatectomy - A propensity score matched longitudinal study.
World J Urol 2024; 42(1)
Westhofen T, Frank K, Buchner A, Becker A, Eismann L, Rodler S, Aydogdu C, Berg E, Jokisch F, Kazmierczak PM, Stief CG, Kretschmer A
